Literature DB >> 29297452

Association between interleukin-17 genetic polymorphisms and tuberculosis susceptibility: an updated meta-analysis.

Z-G Yu1, B-Z Wang2, J Li1, Z-L Ding1, K Wang1.   

Abstract

OBJECTIVE: To investigate the association between the genetic polymorphisms of interleukin-17 (IL-17) and susceptibility to tuberculosis (TB).
METHODS: Relevant case-control studies published up to July 2017 were searched. Odds ratios (ORs) and 95% confidence intervals (CIs) were employed to estimate the association.
RESULTS: Eleven articles involving 4961 TB patients and 5435 healthy controls were selected. Four polymorphic sites were identified: IL-17A rs22275913, rs3748067 and rs3819024; and IL-17F rs763780. We found that the rs2275913 polymorphism was associated with reduced TB risk in Caucasians under the allelic model (A vs. G, OR 0.69, 95%CI 0.49-0.96; P = 0.03), heterogeneous model (AG vs. GG, OR 0.67, 95%CI 0.47-0.93; P = 0.02) and domain model (AA+AG vs. GG, OR 0.64, 95%CI 0.44-0.93; P = 0.02); rs3748067 was associated with increased TB risk in Asians under the homogeneous model (TT vs. CC, OR 1.36, 95%CI 1.03-1.79; P = 0.03) and recessive model (TT vs. CT+CC, OR 1.35, 95%CI 1.02-1.78; P = 0.03). Other genetic variants were not associated with TB risk.
CONCLUSIONS: Our results suggest that the TT genotype of IL-17A rs3748067 might be a risk factor for TB in Asians; the A allele, as well as the AG and AA+AG genotypes of the rs2275913 polymorphism, might be protective against TB in Caucasians. Future studies with a large sample size are needed.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29297452     DOI: 10.5588/ijtld.17.0345

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  8 in total

1.  Friends and foes of tuberculosis: modulation of protective immunity.

Authors:  S Brighenti; S A Joosten
Journal:  J Intern Med       Date:  2018-05-27       Impact factor: 8.989

2.  A Common Variant of ASAP1 Is Associated with Tuberculosis Susceptibility in the Han Chinese Population.

Authors:  Cheng Chen; Qi Zhao; Yan Shao; Yan Li; Honghuan Song; Guoli Li; Limei Zhu; Wei Lu; Biao Xu
Journal:  Dis Markers       Date:  2019-04-08       Impact factor: 3.434

3.  Association between interleukin-17A/F single nucleotide polymorphisms and susceptibility to osteoarthritis in a Chinese population.

Authors:  Lifeng Jiang; Xindie Zhou; Yan Xiong; Jiapeng Bao; Kai Xu; Lidong Wu
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

4.  Lung Neutrophilic Recruitment and IL-8/IL-17A Tissue Expression in COVID-19.

Authors:  Marina Luise Viola Azevedo; Aline Cristina Zanchettin; Caroline Busatta Vaz de Paula; Jarbas da Silva Motta Júnior; Mineia Alessandra Scaranello Malaquias; Sonia Mara Raboni; Plínio Cezar Neto; Rafaela Chiuco Zeni; Amanda Prokopenko; Nícolas Henrique Borges; Thiago Mateus Godoy; Ana Paula Kubaski Benevides; Daiane Gavlik de Souza; Cristina Pellegrino Baena; Cleber Machado-Souza; Lucia de Noronha
Journal:  Front Immunol       Date:  2021-03-30       Impact factor: 7.561

5.  Investigation on Probable Association Between IL-13, IL-13RA1, and IL-13RA2 Genes Polymorphism and Pulmonary Tuberculosis.

Authors:  Hong-Miao Li; Fei Tang; Qian Huang; Hai-Feng Pan; Tian-Ping Zhang
Journal:  J Inflamm Res       Date:  2022-08-08

6.  Association of NOS2A gene polymorphisms with susceptibility to bovine tuberculosis in Chinese Holstein cattle.

Authors:  Jun Chai; Qinglu Wang; Bo Qin; Shengkui Wang; Youtao Wang; Muhammad Shahid; Kai Liu; Yifang Zhang; Weijie Qu
Journal:  PLoS One       Date:  2021-06-17       Impact factor: 3.240

Review 7.  The Role of Immunogenetics in COVID-19.

Authors:  Fanny Pojero; Giuseppina Candore; Calogero Caruso; Danilo Di Bona; David A Groneberg; Mattia E Ligotti; Giulia Accardi; Anna Aiello
Journal:  Int J Mol Sci       Date:  2021-03-05       Impact factor: 5.923

Review 8.  Influence of Genetic Polymorphism Towards Pulmonary Tuberculosis Susceptibility.

Authors:  Murugesan Harishankar; Paramasivam Selvaraj; Ramalingam Bethunaickan
Journal:  Front Med (Lausanne)       Date:  2018-08-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.